Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 860 results for "merck co"

Market Update: Merck & Co Inc (NYSE:MRK)  Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers
Jutia Group

Merck Acquires OncoEthix For $110 Mln Plus Milestone Payments ...

Drugmaker Merck (MRK: Quote) said it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately-held biotechnology company specializing in oncology drug development. Financial terms of the acquisition include an upfront payment of up ... RTTNews.com, 13 hours ago
Merck Acquires OncoEthix of Switzerland MedNous, 9 hours ago
[x]  

91 images for merck co

Jutia Group, 8 hours ago
Bidness Etc, 2 days ago
Boston Globe, 4 days ago
Boston Globe, 1 day ago
Bidness Etc, 1 week ago
Bidness Etc, 1 week ago
Bidness Etc, 1 week ago
Bidness Etc, 1 week ago
San Francisco Chronicle, 1 week ago
InsiderMonkey.com, 1 week ago

Merck acquires OncoEthix

Merck & Co., Inc., through its subsidiary, has acquired OncoEthix SA, a Switzerland-based clinical stage biotechnology company engaged in the development of new drugs for cancer treatment. Merck is a US-based research-driven pharmaceutical company ...
 Individual.com5 hours ago
Reuters

OncoEthix acquired by Merck

OncoEthix SA, a Switzerland-based clinical stage biotechnology company engaged in the development of new drugs for cancer treatment, has been acquired by subsidiary of Merck & Co., Inc., a US-based research-driven pharmaceutical company. Pursuant to ...
 Individual.com5 hours ago MERCK : Acquires OncoEthix for Up to $375 Million  4 Traders12 hours ago Merck & Co. buys cancer drug developer OncoEthix for up to $375 million  FirstWord Pharma13 hours ago The Wall Street Journal: Merck acquires OncoEthix for up to $375 million  Austin American Statesman12 hours ago
[x]  
Malta Independent Daily

Drugmaker Merck buys Swiss biotech with promising experimental drug for tumors, blood cancers

KENILWORTH, N.J. Drugmaker Merck says it's bought a Swiss biotech company developing cancer drugs as part of its strategy to be a top player in cancer, one of the hottest pharmaceutical research areas. Merck & Co., based in Kenilworth, New ...
 FOXBusiness.com8 hours ago Merck buys Swiss biotech with promising cancer drug  FOXBusiness.com8 hours ago
[x]  
Reuters India

UPDATE 1-New GSK shingles vaccine may challenge Merck after strong test data

* GSK vaccine cuts risk of shingles by 97.2 pct in over 50s * Potentially strong competitor for Merck's Zostavax * Shares in GSK partner Agenus jump 10 percent (Adds sales figures for Merck vaccine, forecast for GSK product) LONDON, Dec ...
 CNBC10 hours ago New GlaxoSmithKline shingles vaccine may challenge Merck & Co after strong test data  Economic Times8 hours ago New GSK shingles vaccine may challenge Merck after strong test data  Reuters India9 hours ago GSK shingles vaccine candidate meets Ph III primary endpoint  Pharma Letter8 hours ago
[x]  

Merck (MRK) Showing Support Near $56.09

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Merck & Co Inc. (http://www.marketintelligencecenter.com/symbol/MRK"MRK) that should provide a ...
 Individual.com12 hours ago Merck (MRK) Trading Near $56.01 Support Level  Individual.com2 days ago
Bidness Etc

MRK Crosses Above Key Moving Average Level

In trading on Thursday, shares of Merck & Co., Inc (Symbol: MRK) crossed above their 200 day moving average of $57.96, changing hands as high as $58.75 per share. Merck & Co., Inc shares are currently trading up about 1.5% on the day. The chart ...
 Nasdaq9 hours ago Merck & Co. Receives Consensus Recommendation of Buy from Brokerages (NYSE:MRK)  Ticker Report1 day ago Merck and Co. (MRK) Seeks $8 Billion Bridge Loan To Acquire Cubist Pharmaceuticals (CBST)  Bidness Etc2 days ago TRLPC: Merck looks for $8B bridge for Cubist acquisition  Reuters3 days ago
[x]  

IBCSG, BIG and Merck announce initiation of HER2+ breast cancer study

The International Breast Cancer Study Group, or IBCSG, Breast International Group, or BIG, and Merck have announced the initiation of PANACEA study, to investigate the use of pembrolizumab in combination with trastuzumab to evaluate whether the ...
 Individual.com1 day ago

The Zacks Analyst Blog Highlights: Chevron, Statoil, Merck, Boeing and General Electric

Comments CHICAGO, Dec. 15, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...
 AndhraNews.net2 days ago

Merck & Co Inc to buy Cubist Pharmaceuticals Inc for $9.5 billion

The deal is the latest sign that large pharmaceutical companies are turning their attention back to antibiotics after decades of low investment. Merck & Co Inc said it would buy Cubist Pharmaceuticals Inc for $8.4 billion plus assumption of debt, giving the ...
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less